April 28 (Reuters) – British equities ended higher on Monday with heavyweight healthcare companies leading gains in the benchmark index, while U.S. trade policy developments remained in focus.
The blue-chip FTSE 100 (.FTSE), was nearly flat but posted its 11th consecutive winning session. The index also posted its longest winning streak since December 2019.
The midcap FTSE 250 (.FTMC), gained 0.6%.
Healthcare stocks (.FTNMX452010), gained 1.1%, with AstraZeneca (AZN.L), and GSK (GSK.L), boosting the highest gains in the FTSE 100, up 1.2% and 1.4% respectively.
Market sentiment was supported by signs of easing U.S.-China trade tensions last week. However, uncertainties about the global trade war continued.
Entain finished (ENT.L), up 6.8%, after the British gambling firm’s joint venture with MGM Resorts (MGM.N), BetMGM, swung to first-quarter profit in an e-betting surge.
Deliveroo (ROO.L), jumped 16.5%, leading the gains on the midcap…
